Phathom Pharmaceuticals, Inc.
PHAT
$10.58
-$0.21-1.95%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -56.28% | -59.62% | -45.85% | -34.11% | -22.06% |
| Total Receivables | 101.38% | 165.01% | 371.22% | 837.46% | 2,270.01% |
| Inventory | 72.01% | 16.07% | 57.60% | 117.15% | 165.56% |
| Prepaid Expenses | -26.42% | -11.70% | -5.66% | 2.41% | 58.15% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -36.42% | -44.42% | -28.19% | -22.16% | -9.38% |
|
|
|||||
| Total Current Assets | -36.42% | -44.42% | -28.19% | -22.16% | -9.38% |
| Net Property, Plant & Equipment | 75.54% | 54.74% | -26.13% | -46.00% | -42.31% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 64.71% | 166.94% | 149.30% | 112.72% | 25.85% |
| Total Assets | -31.50% | -37.92% | -21.65% | -17.47% | -8.58% |
|
|
|||||
| Total Accounts Payable | -52.57% | -84.93% | -47.65% | 38.25% | -16.62% |
| Total Accrued Expenses | 66.83% | 80.02% | 129.96% | 151.18% | 199.53% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 37.57% | 19.45% | 104.74% | 2.19% | 158.75% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 54.03% | 42.63% | 95.33% | 70.35% | 121.06% |
|
|
|||||
| Total Current Liabilities | 54.03% | 42.63% | 95.33% | 70.35% | 121.06% |
| Long-Term Debt | 4.59% | 11.64% | 11.41% | 21.15% | 22.17% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | 342.86% | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -65.22% | 6.98% | 10.05% | 18.56% | 18.56% |
| Total Liabilities | 10.35% | 15.44% | 18.59% | 25.26% | 29.86% |
|
|
|||||
| Common Stock & APIC | 3.63% | 3.91% | 18.20% | 18.07% | 17.93% |
| Retained Earnings | -17.52% | -23.10% | -29.93% | -34.18% | -36.00% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -72.79% | -125.82% | -73.56% | -127.86% | -248.52% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -72.79% | -125.82% | -73.56% | -127.86% | -248.52% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -72.79% | -125.82% | -73.56% | -127.86% | -248.52% |
|
|
|||||